---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-26-018464"
form_type: "8-K"
ticker: "PDSB"
cik: "0001472091"
company_name: "PDS Biotechnology Corp"
filed_at: "2026-05-01T23:59:59+00:00"
generated_at: "2026-05-15T00:17:13.115835+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# PDS Biotechnology issues $6M promissory note and warrant to YA II PN, redeems existing debentures

## Summary
- Entered $6M promissory note at 10% interest, 12-month maturity, issued at $5.76M (96% of face).
- Issued warrant for 2,158,274 shares at $1.1824, exercisable after 6 months for 5 years.
- Redeeming existing Senior Secured Convertible Debentures at 103% of principal plus accrued interest on June 12, 2026.
- Terminated prior sales agreement with B. Riley and H.C. Wainwright; entered new ATM with Yorkville Securities.
- Note includes conversion rights upon default at discounted VWAP; warrant has cashless exercise option.

## SEC filing metadata
- accession: 0001140361-26-018464
- form_type: 8-K
- ticker: PDSB
- cik: 0001472091
- company_name: PDS Biotechnology Corp
- filed_at: 2026-05-01T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 1.02, 2.03, 3.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1472091/000114036126018464/0001140361-26-018464-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1472091/000114036126018464/ef20072168_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-26-018464
- JSON: https://secwatch.observer/filing/0001140361-26-018464.json
- Plain text: https://secwatch.observer/filing/0001140361-26-018464.txt

## Source-grounded claims
- claim_id: 09c1b714a4ea0d9e30132fd13bf185b19e948de6
  claim: PDS Biotechnology Corp incurred loan of $6,000,000 with YA II PN, LTD. at 10% per annum maturing twelve-month anniversary of the Closing Date.
  evidence_excerpt: Promissory Note will have an aggregate face value of $6,000,000 and will be issued on the Closing Date for a purchase price of $5,760,000. The Promissory Note will have a maturity date of the twelve-month anniversary of the Closing Date and an interest rate of 10% per annum
  evidence_url: https://www.sec.gov/Archives/edgar/data/1472091/000114036126018464/0001140361-26-018464-index.htm
- claim_id: 3ef0aea0396ce1d96c8f6f41a43a31d835e358ce
  claim: PDS Biotechnology Corp entered into Securities Purchase Agreement with YA II PN, LTD. valued at $6,000,000 (effective 2026-04-30).
  evidence_excerpt: On April 30, 2026 (the “ Effective Date ”), PDS Biotechnology Corporation, a Delaware corporation (the “ Company ”), entered into a Securities Purchase Agreement (the “ Purchase Agreement ”) with YA II PN, LTD.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1472091/000114036126018464/0001140361-26-018464-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.